investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Validating Syk as a Target for AML Therapy

Kimberly Stegmaier

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Michael Kharas

Characterizing MSI2 in leukemia

Leukaemia

Catherine Ju-Ying Wu

The role of the SF3B1 splicing factor in chronic lymphocytic leukemia

Leukaemia

Neil Osheroff

Function and Biology of Eukaryotic DNA Topoisomerases

Leukaemia

David A Scheinberg

Mechanisms of action of a TCR-like antibody to WT1

Leukaemia

Nya D Nelson

Elucidating the role of TIN2L at the telomere and in dyskeratosis congenita

Leukaemia

Pathology

Julie Aurore Losman

The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia

Leukaemia

Daniel McVicar

Characterization of the Expression and Ligands of KIR3DS2

Leukaemia

Pathology Hematology and hematologic malignancies

Scott H Kaufmann

Regulation of Death Ligand-Induced Killing

Leukaemia

Pathology Hematology and hematologic malignancies

Thomas Waldmann

IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

Leukaemia

Pathology Hematology and hematologic malignancies